Patents by Inventor Frédéric Denonne

Frédéric Denonne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943605
    Abstract: The present invention relates to compounds of formula (I) comprising a lactam or a lactam derivative moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as pharmaceuticals.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: May 17, 2011
    Assignee: UCB Pharma S.A.
    Inventors: Sylvain Celanire, Luc Quere, Frédéric Denonne, Laurent Provins
  • Publication number: 20110098300
    Abstract: The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals, useful for the treatment and prevention of diseases or pathological conditions of the central nervous system including mild-cognitive impairments, Alzheimer's disease, learning and; memory disorders, cognitive disorders, attention deficit disorder, attention-deficit hyperactivity disorder, Parkinson's disease, schizophrenia, dementia, depression, epilepsy, seizures, convulsions, sleep/wake and arousal/vigilance disorders such as hypersomnia and narcolepsy, pain and/or obesity.
    Type: Application
    Filed: June 2, 2009
    Publication date: April 28, 2011
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Laurent Provins, Frederic Denonne, Anne Valade
  • Patent number: 7863450
    Abstract: The present invention relates to compounds comprising an oxazoline or thiazoline moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3-receptor ligands, (I), wherein A1 is CH C(CH3) or N; R1 is hydrogen or halogen; R2 is (II); A2 is O or S; R3 is hydrogen, halogen, C1-4 alkyl or C1-4 alkoxy; R4 is hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, trifluoromethyl or —O—(CH2)n-NR12aR each CH2 in —O—(CH2)n-NR12aR12b being optionally substituted by one or two C1-4 alkyl; R5 is hydrogen or —O—(CH2)m—NR13aR13b, each CH2 in —O—(CH2)m—NR13aR13b being optionally substituted by one or two C1-4 alkyl, and at least one of R4 and R5 should be a —O—(CH2)n-NR12/13aR12/13b group.
    Type: Grant
    Filed: March 29, 2006
    Date of Patent: January 4, 2011
    Assignee: UCB Pharma, S.A.
    Inventors: Sylvain Celanire, Patrice Talaga, Regorius Leurs, Frederic Denonne, Henkdrik Timmerman, Florence Lebon
  • Publication number: 20100305116
    Abstract: The present invention relates to compounds comprising a cyclobutoxy group, processes for preparing them, phar-maceutical compositions comprising said compounds and their use as pharmaceuticals.
    Type: Application
    Filed: April 14, 2008
    Publication date: December 2, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Frederic Denonne, Anne Valade
  • Publication number: 20100292188
    Abstract: The present invention relates to compounds of formula (I) comprising a cyclobutoxy group, processes for preparing them, pharmaceutical compositions comprising said compounds and their use as pharmaceuticals.
    Type: Application
    Filed: January 22, 2009
    Publication date: November 18, 2010
    Applicant: UCB PHARMA S.A.
    Inventors: Frédéric Denonne, Sylvain Celanire, Anne Valade, Sabine Defays, Véronique Durieu
  • Patent number: 7790720
    Abstract: The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3-receptor ligands, Formula (I), wherein, A1 is CH, C(alkyl), C-halogen or N; R1 is hydrogen, halogen, C1-6 alkyl or alkoxy; R2 is, Formula (II?), A3 is O or S; R3 is hydrogen, halogen, C1-6 alkyl or alkoxy; R4 is hydrogen, halogen, C1-6 alkyl, alkoxy or —O-L; R5 is hydrogen or —O-L, wherein L is an aminoalkyl group and at least one of R4 and R5 should be —O-L.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: September 7, 2010
    Assignee: UCB Pharma, S.A.
    Inventors: Sylvain Celanire, Frederic Denonne
  • Publication number: 20100009969
    Abstract: The present invention relates to compounds comprising fused oxazole or thiazole derivatives of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3-receptor ligands, wherein A is a cyclic amine which is linked to the propylene group via an amino nitrogen; B is selected from the group consisting of heteroaryl, 5-8-membered heterocycloalkyl, 5-8-membered cycloalkyl; X is either N or CH; Y is either O or S.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 14, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Frédéric Denonne, Sylvain Celanire, Laurent Provins, Sabine Defays
  • Publication number: 20090023708
    Abstract: The present invention relates to compounds of formula (I) comprising a lactam or a lactam derivative moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as pharmaceuticals.
    Type: Application
    Filed: October 25, 2006
    Publication date: January 22, 2009
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Luc Quere, Frederic Denonne, Laurent Provins
  • Publication number: 20080275046
    Abstract: The present invention relates to compounds comprising an oxazole or thiazole moiety of formula (I), processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3-receptor ligands, Formula (I), wherein, A1 is CH, C(alkyl), C-halogen or N; R1 is hydrogen, halogen, C1-6 alkyl or alkoxy; R2 is, Formula (II?), A3 is O or S; R3 is hydrogen, halogen, C1-6 alkyl or alkoxy; R4 is hydrogen, halogen, C1-6 alkyl, alkoxy or —O-L; R5 is hydrogen or —O-L, wherein L is an aminoalkyl group and at least one of R4 and R5 should be —O-L.
    Type: Application
    Filed: March 28, 2006
    Publication date: November 6, 2008
    Applicant: UCB PHARMA, S.A.
    Inventors: Sylvain Celanire, Frederic Denonne
  • Publication number: 20080161331
    Abstract: The present invention relates to compounds comprising an oxazoline or thiazoline moiety, processes for preparing them, pharmaceutical compositions comprising said compounds and their uses as H3-receptor ligands, (I), wherein A1 is CH C(CH3) or N; R1 is hydrogen or halogen; R2 is (II); A2 is O or S; R3 is hydrogen, halogen, C1-4 alkyl or C1-4 alkoxy; R4 is hydrogen, halogen, C1-4 alkyl, C1-4 alkoxy, trifluoromethyl or —O—(CH2)n-NR12aR each CH2 in —O—(CH2)n-NR12aR 12b being optionally substituted by one or two C1-4 alkyl; R5 is hydrogen or —O—(CH2)m—NR13aR13b, each CH2 in —O—(CH2)m—NR13aR13b being optionally substituted by one or two C1-4 alkyl, and at least one of R4 and R5 should be a —O—(CH2)n-NR12/13aR12/13b group.
    Type: Application
    Filed: March 29, 2006
    Publication date: July 3, 2008
    Applicant: UCB PHARMA, S.A.
    Inventors: Regorius Leurs, Henkdrik Timmerman, Sylvain Celanire, Patrice Talaga, Frederic Denonne, Florence Lebon